Picture of Alk-Abello A/S logo

ALK B — Alk-Abello A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: ALK-Abello's Itulazax Approved For Treatment Of Children In Europe

April 23 (Reuters) - ALK-Abello A/S ALKb.CO:

ITULAZAX TREE POLLEN TABLET APPROVED FOR TREATMENT OF CHILDREN IN EUROPE

FIRST MARKET INTRODUCTIONS TO FOLLOW IN COMING MONTHS

APPROVAL IS NOT EXPECTED TO AFFECT ALK'S FINANCIAL OUTLOOK FOR 2025

Source text: ID:nGNEp5Y3F

Further company coverage: [ALKb.CO]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Alk-Abello A/S

See all news